Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChAdOx1 Vaccine Dose-Sparing Strategies in Post COVID-19 Patients
TCTR20211004005Phase 2Not yet recruiting
- Sponsor
- National Research Council of Thailand
- Start
- Aug 2022
- Modality
- Viral Vector Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of ChAdOx1 nCoV-19 in coronavirus disease 2019 (COVID-19), sponsored by National Research Council of Thailand. Planned start Aug 2022; status: not yet recruiting.
02
Drugs
ChAdOx1 nCoV-19
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20211004005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20211004005.